167 related articles for article (PubMed ID: 10600476)
1. New insight into abnormal prion protein using monoclonal antibodies.
Demart S; Fournier JG; Creminon C; Frobert Y; Lamoury F; Marce D; Lasmézas C; Dormont D; Grassi J; Deslys JP
Biochem Biophys Res Commun; 1999 Nov; 265(3):652-7. PubMed ID: 10600476
[TBL] [Abstract][Full Text] [Related]
2. Species-specificity of a panel of prion protein antibodies for the immunohistochemical study of animal and human prion diseases.
Furuoka H; Yabuzoe A; Horiuchi M; Tagawa Y; Yokoyama T; Yamakawa Y; Shinagawa M; Sata T
J Comp Pathol; 2007 Jan; 136(1):9-17. PubMed ID: 17270205
[TBL] [Abstract][Full Text] [Related]
3. Generation of antibodies against bovine recombinant prion protein in various strains of mice.
Andrievskaia O; McRae H; Elmgren C; Huang H; Balachandran A; Nielsen K
Clin Vaccine Immunol; 2006 Jan; 13(1):98-105. PubMed ID: 16426006
[TBL] [Abstract][Full Text] [Related]
4. A single prion protein peptide can elicit a panel of isoform specific monoclonal antibodies.
Vranac T; Hartman KP; Popović M; Venturini A; Zerovnik E; Curin Serbec V
Peptides; 2006 Nov; 27(11):2695-705. PubMed ID: 16859811
[TBL] [Abstract][Full Text] [Related]
5. The same prion strain causes vCJD and BSE.
Hill AF; Desbruslais M; Joiner S; Sidle KC; Gowland I; Collinge J; Doey LJ; Lantos P
Nature; 1997 Oct; 389(6650):448-50, 526. PubMed ID: 9333232
[No Abstract] [Full Text] [Related]
6. Is the prion structure solved?
Liberski PP; Bratosiewicz-Zapart J
Arch Immunol Ther Exp (Warsz); 1997; 45(2-3):121-40. PubMed ID: 9597078
[TBL] [Abstract][Full Text] [Related]
7. Identification of a second bovine amyloidotic spongiform encephalopathy: molecular similarities with sporadic Creutzfeldt-Jakob disease.
Casalone C; Zanusso G; Acutis P; Ferrari S; Capucci L; Tagliavini F; Monaco S; Caramelli M
Proc Natl Acad Sci U S A; 2004 Mar; 101(9):3065-70. PubMed ID: 14970340
[TBL] [Abstract][Full Text] [Related]
8. Inhibition of prion propagation in scrapie-infected mouse neuroblastoma cell lines using mouse monoclonal antibodies against prion protein.
Miyamoto K; Nakamura N; Aosasa M; Nishida N; Yokoyama T; Horiuchi H; Furusawa S; Matsuda H
Biochem Biophys Res Commun; 2005 Sep; 335(1):197-204. PubMed ID: 16061207
[TBL] [Abstract][Full Text] [Related]
9. [Prions and transmissible neurodegenerative diseases].
Domínguez García A; Mata Albert E; Salleras Sanmartí L
Med Clin (Barc); 1998 May; 110(19):751-7. PubMed ID: 9672870
[No Abstract] [Full Text] [Related]
10. Synthetic peptide vaccines yield monoclonal antibodies to cellular and pathological prion proteins of ruminants.
Harmeyer S; Pfaff E; Groschup MH
J Gen Virol; 1998 Apr; 79 ( Pt 4)():937-45. PubMed ID: 9568991
[TBL] [Abstract][Full Text] [Related]
11. Characterisation of new monoclonal antibodies reacting with prions from both human and animal brain tissues.
Cordes H; Bergström AL; Ohm J; Laursen H; Heegaard PM
J Immunol Methods; 2008 Sep; 337(2):106-20. PubMed ID: 18657541
[TBL] [Abstract][Full Text] [Related]
12. [What are the prions?].
Piédrola Angulo G
An R Acad Nac Med (Madr); 2001; 118(3):599-604. PubMed ID: 11783039
[No Abstract] [Full Text] [Related]
13. Identification of an epitope on the recombinant bovine PrP that is able to elicit a prominent immune response in wild-type mice.
Cernilec M; Vranac T; Hafner-Bratkovic I; Koren S; Venturini AC; Popović M; Juntes P; Serbec VC
Immunol Lett; 2007 Oct; 113(1):29-39. PubMed ID: 17884181
[TBL] [Abstract][Full Text] [Related]
14. Monoclonal antibodies inhibit prion replication and delay the development of prion disease.
White AR; Enever P; Tayebi M; Mushens R; Linehan J; Brandner S; Anstee D; Collinge J; Hawke S
Nature; 2003 Mar; 422(6927):80-3. PubMed ID: 12621436
[TBL] [Abstract][Full Text] [Related]
15. Antibodies to the scrapie protein decorate prion rods.
Barry RA; McKinley MP; Bendheim PE; Lewis GK; DeArmond SJ; Prusiner SB
J Immunol; 1985 Jul; 135(1):603-13. PubMed ID: 3923112
[TBL] [Abstract][Full Text] [Related]
16. Anchorless prion protein results in infectious amyloid disease without clinical scrapie.
Chesebro B; Trifilo M; Race R; Meade-White K; Teng C; LaCasse R; Raymond L; Favara C; Baron G; Priola S; Caughey B; Masliah E; Oldstone M
Science; 2005 Jun; 308(5727):1435-9. PubMed ID: 15933194
[TBL] [Abstract][Full Text] [Related]
17. [Induction of immune response by synthetic fragments of the bovine prion protein and their analogues in mice of various lines].
Oboznaia MB; Vol'pina OM; Zhmak MN; Titova MA; Volkova TD; Egorov AA; Rybakov SS; Ivanov VT
Bioorg Khim; 2004; 30(4):356-63. PubMed ID: 15469008
[TBL] [Abstract][Full Text] [Related]
18. In vitro evaluation of the anti-prionic activity of newly synthesized congo red derivatives.
Poli G; Ponti W; Carcassola G; Ceciliani F; Colombo L; Dall'Ara P; Gervasoni M; Giannino ML; Martino PA; Pollera C; Villa S; Salmona M
Arzneimittelforschung; 2003; 53(12):875-88. PubMed ID: 14750496
[TBL] [Abstract][Full Text] [Related]
19. The role of antibodies to PrP in the diagnosis of transmissible spongiform encephalopathies.
Kascsak RJ; Tonna-DeMasi M; Fersko R; Rubenstein R; Carp RI; Powers JM
Dev Biol Stand; 1993; 80():141-51. PubMed ID: 8270104
[TBL] [Abstract][Full Text] [Related]
20. Ecosystems supporting clusters of sporadic TSEs demonstrate excesses of the radical-generating divalent cation manganese and deficiencies of antioxidant co factors Cu, Se, Fe, Zn. Does a foreign cation substitution at prion protein's Cu domain initiate TSE?
Purdey M
Med Hypotheses; 2000 Feb; 54(2):278-306. PubMed ID: 10790765
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
